Kedrab: 1st pediatric trial for Human Rabies Immune Globulin
Outbreak News2 Sep 2020

Kedrab: 1st pediatric trial for Human Rabies Immune Globulin

Rabies post exposure prophylaxis, or PEP, consists of a rabies vaccine series and human rabies immune globulin (HRIG).

Kedrion Biopharma's human rabies immune globulin, Kedrab, was FDA approved in 2017. And now for the first time, the safety of HRIG (Kedrab) was studied in children.

Joining me today to discuss rabies, PEP and the pediatric trial is James Linakis, MD, PhD. Dr. Linakis is Professor of Emergency Medicine and Pediatrics at Brown Medical School and Associate Director of Pediatric Emergency Medicine at Rhode Island Hospital's Hasbro Children's Hospital.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(535)

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
aftenpodden-usa
popradet
forklart
fotballpodden-2
stopp-verden
rss-gukild-johaug
det-store-bildet
nokon-ma-ga
rss-espen-lee-usensurert
lydartikler-fra-aftenposten
dine-penger-pengeradet
hanna-de-heldige
rss-ness
aftenbla-bla
frokostshowet-pa-p5
rss-penger-polser-og-politikk
e24-podden
liverpoolno-pausepraten